Exome/Genome-Wide Testing in Newborn Screening: A Proportionate Path Forward
Population-based newborn screening (NBS) is among the most effective public health programs ever launched, improving health outcomes for newborns who screen positive worldwide through early detection and clinical intervention for genetic disorders discovered in the earliest hours of life. Key to the...
Main Authors: | Vasiliki Rahimzadeh, Jan M. Friedman, Guido de Wert, Bartha M. Knoppers |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2022-07-01
|
Series: | Frontiers in Genetics |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fgene.2022.865400/full |
Similar Items
-
Cancer Patient Experience of Uncertainty While Waiting for Genome Sequencing Results
by: Nicci Bartley, et al.
Published: (2021-04-01) -
Parental Attitudes Toward Standard Newborn Screening and Newborn Genomic Sequencing: Findings From the BabySeq Study
by: Brittan Armstrong, et al.
Published: (2022-04-01) -
Select Ethical Aspects of Next-Generation Sequencing Tests for Newborn Screening and Diagnostic Evaluation of Critically Ill Newborns
by: Kuntal Sen, et al.
Published: (2021-11-01) -
Editorial: Unveiling novel aspects of SARS-CoV-2 to combat COVID-19
by: Nimisha Ghosh, et al.
Published: (2024-02-01) -
A policy Delphi study to validate the key implications of data sharing (KIDS) framework for pediatric genomics in Canada
by: Vasiliki Rahimzadeh, et al.
Published: (2021-06-01)